Global Invertase valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major driving factor of global Invertase are rising demand for innovative products among consumers related to food & beverages sector and increase its applicability in pharmaceutical industry. The major restraining factors of Invertase are less access to the natural enzyme, high operational cost and products involving the usage the usage of invertase enzyme are not recommendable for diabetic patients. Invertase is an enzyme that catalyzes the hydrolysis of sucrose into fructose and glucose. Alternative names of invertase are saccharase, glucosucrase, beta-h-fructosidase, beta-fructosidase, invertin, sucrase, maxinvert L 1000, fructosylinvertase, alkaline invertase, acid invertase, and the systematic name: beta-fructofuranosidase. Invertase is used in the process of commercial banking owing to the benefit of capability to retain the moisture for longer time period. Other benefits of invertase are it helps to reduce stomach toxicity, it is mainly used as food additive, it improves the digestion and it also helps to combat cancer and provides antioxidant support.

The regional analysis of Global Invertase is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America has dominated the market of total generating revenue across the globe due to consumers are interested in natural products and invertase is available as a natural ingredient. Europe is also contributing major share in the global market of Internet of vehicle. Asia-Pacific region is also anticipated to exhibit higher growth rate / CAGR over the over the forecasted period 2018-2025 due to opportunistic platform that is provided for the research & development.

The major market player included in this report are:

  • Sigma-Aldrich Co. LLC
  • Koninklijke DSM N.V.
  • Parchem Fine & Speciality Chemicals
  • SternEnzym GmbH & Co. KG
  • Kerry Inc.
  • Meteoric Exim Private Ltd.
  • MP Biomedicals LLC
  • BIO-CAT
  • Megazyme Inc


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Industry:

  • Food & Beverage
  • Pharmaceuticals
  • Personal Care
  • Others


By Source:

  • Plant
  • Microorganism


By Regions:

  • North America


o U.S.
o Canada

  • Europe


o UK
o Germany

  • Asia Pacific


o China
o India
o Japan

  • Latin America


o Brazil
o Mexico

  • Rest of the World


Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

Target Audience of the Global Invertase in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors